en
Scientific article
English

Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo

Published inExperimental dermatology, vol. 15, no. 8, p. 634-642
Publication date2006
Abstract

Pro-inflammatory chemokines and their receptors exhibit elementary functions in cell migration and in Th1-driven inflammatory conditions. One therapeutic strategy to prevent accumulation of pro-inflammatory immune cells is the use of specific chemokine receptor antagonists. An interesting and promising candidate in this context is the viral antagonist MIP-II (vMIP-II) that acts on a broad spectrum of chemokine receptors. To study the in vitro and in vivo effects of vMIP-II on pro-inflammatory chemokine receptor function, we further characterized an ovalbumin-specific murine central memory Th1IF12 clone by using RT-PCR, cDNA array and cytometry. Using in vitro chemotaxis assays we show that eukaryotically generated vMIP-II strongly inhibited migration of CCL2- or CCL5-stimulated Th1 IF12 cells. Using intravital microscopy, we observed that CCL5 induced rolling of Th1 cells in the ear vasculature of C57Bl/6 mice. Pre-treatment with vMIP-II significantly reduced CCL5-induced rolling of Th1 cells to basal levels, indicating, that vMIP-II is also active in vivo (proportion of rolling cells: 19.4 +/- 3.8%, 39.8 +/- 2.9% and 26.1 +/- 3.2%). In addition, investigating the anti-inflammatory action of vMIP-II in adoptive transfer of immunity and dinitrofluorobenzene-induced cutaneous hypersensitivity reaction using C57Bl/6 mice, we show a direct inhibitory effect of vMIP-II on the sensitization phase [Delta ear swelling 62 and 37 cm x 10(-3) for controls and vMIP-II treated mice (2.5 mg/kg), respectively] and effector phase (Delta ear swelling 14.8 and 3.6 cm x 10(-3) for controls and vMIP-II treated mice (2.5 mg/kg), respectively) of cutaneous hypersensitivity. These data indicate that vMIP-II is a promising agent to interfere with chronic inflammatory (skin) diseases.

Keywords
  • Animals
  • Anti-HIV Agents/*pharmacology
  • Anti-Inflammatory Agents/pharmacology
  • Chemokines/*pharmacology
  • Chemotaxis
  • Dermatitis, Contact
  • Humans
  • Lymphocytes/metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Chemokine/*antagonists & inhibitors
  • Recombinant Proteins/chemistry
  • T-Lymphocytes/drug effects/*immunology
Affiliation Not a UNIGE publication
Citation (ISO format)
RUBANT, Simone A. et al. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo. In: Experimental dermatology, 2006, vol. 15, n° 8, p. 634–642. doi: 10.1111/j.1600-0625.2006.00455.x
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0906-6705
524views
0downloads

Technical informations

Creation09/20/2013 4:48:30 PM
First validation09/20/2013 4:48:30 PM
Update time03/14/2023 8:25:25 PM
Status update03/14/2023 8:25:25 PM
Last indexation02/12/2024 8:32:18 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack